News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

American Academy of Ophthalmology: Retinoid Drug May Slow Dry AMD Progression


10/19/2010 6:56:05 AM

MedPageToday -- CHICAGO -- Fenretinide could still become the first disease-modifying treatment for geographic atrophy -- the end stage of "dry" age-related macular degeneration (AMD) -- in spite of a bungled phase II trial, researchers said here.

Read at MedPageToday


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES